梅州慢性尿道炎表现-【梅州曙光医院】,梅州曙光医院,梅州怎样治妇科宫颈糜烂,梅州做人流那家医院好,梅州念珠菌性阴道炎如何医疗,梅州治疗阴道炎到哪个医院,梅州处女膜修复手术需要几天,梅州速效诊断白带异常
梅州慢性尿道炎表现梅州月经老是来,梅州盆腔炎的治疗方法,梅州阴到炎的治疗,梅州慢性盆腔炎可以怀孕吗,梅州眼部提升术需要多少钱,梅州阴道炎 医治,梅州额头填充脂肪价格表
August is usually an exciting time to be an educator, as Teachers start decorating their classrooms and preparing for a new group of students.This year, however, many teachers are experiencing a new set of emotions.“My colleagues are fearful,” said Tanya Kitts-Lewinski, president of the Kenosha Education Association in Wisconsin.Kitts-Lewinski says many teachers are fearful of returning to campus during the COVID-19 crisis. Now, she’s calling out the safety of teaching during this pandemic, even virtually, saying some schools are requiring teachers to teach online from inside a classroom.“We can’t serve our students if we’re sick,” she said.Now a local law firm is preparing for the worst by offering free wills to teachers returning to classrooms."People are very scared, and this is the one thing I can do to help this group, and I'm committed to doing as much as I can," said Jim Brzezinski, a partner at Tabak Law in Milwaukee, Wisconsin.Brzezinski came up with this idea after talking with his wife, who is also a teacher. After posting this service online, the response was overwhelming."Within 12 hours of opening up this to teachers, we got about 300 requests within the first 12 hours," he said.We reached out to the Kenosha Unified School District, but they wouldn't talk on camera. Off camera, they said they plan on returning to school virtually, then reassessing the status of the pandemic and determining if and when it's safe to return to in-person learning."We frankly don't have enough educators to make our classrooms small enough to follow CDC guidelines," Kitts-Lewinski said, adding she won't feel safe returning to the classroom until the virus is fully contained."If we're not alive," she said. "We can't serve our students." 1764
August is usually an exciting time to be an educator, as Teachers start decorating their classrooms and preparing for a new group of students.This year, however, many teachers are experiencing a new set of emotions.“My colleagues are fearful,” said Tanya Kitts-Lewinski, president of the Kenosha Education Association in Wisconsin.Kitts-Lewinski says many teachers are fearful of returning to campus during the COVID-19 crisis. Now, she’s calling out the safety of teaching during this pandemic, even virtually, saying some schools are requiring teachers to teach online from inside a classroom.“We can’t serve our students if we’re sick,” she said.Now a local law firm is preparing for the worst by offering free wills to teachers returning to classrooms."People are very scared, and this is the one thing I can do to help this group, and I'm committed to doing as much as I can," said Jim Brzezinski, a partner at Tabak Law in Milwaukee, Wisconsin.Brzezinski came up with this idea after talking with his wife, who is also a teacher. After posting this service online, the response was overwhelming."Within 12 hours of opening up this to teachers, we got about 300 requests within the first 12 hours," he said.We reached out to the Kenosha Unified School District, but they wouldn't talk on camera. Off camera, they said they plan on returning to school virtually, then reassessing the status of the pandemic and determining if and when it's safe to return to in-person learning."We frankly don't have enough educators to make our classrooms small enough to follow CDC guidelines," Kitts-Lewinski said, adding she won't feel safe returning to the classroom until the virus is fully contained."If we're not alive," she said. "We can't serve our students." 1764
As our country works to rebound, we're helping you manage the pressure as the pandemic is shifting caregiving responsibilities.More millennials are taking on this responsibility now. They're becoming a greater percentage of what's known as the "sandwich generation." Those are people who are caring for both their own kids and their aging parents.New numbers from insurance company New York Life show a third of millennials are doing this now.“We're not replacing the typical 49-year-old woman who's the family caregiver. She's still doing it, but the need is so great that more and more young people are called into the role as well and that's going to continue well after the COVID pandemic,” said John Schall, CEO of the Caregiver Action Network.Nearly half of the so-called "sandwich generation" expect to be a caregiver in some capacity for six or more years.The added financial strain is one concern. Schall says out of pocket expenses can be about a thousand dollars a month.More than half of these caregivers say they're spending more than usual per month to care for others as a result of the pandemic. That means they're contributing less to their savings and their retirement.There's also the concern about the mental toll.“With millennial generation caregivers, you may not be thinking about depression, you know, at that age, but the fact is the sheer stress of the role of being a family caregiver increases that risk of depression twice as often,” said Schall.If you are feeling overwhelmed, the caregiver help desk from the Caregiver Action Network can be one place to turn. You can call them free of charge at 855-227-3640. 1648
At a White House news conference on Friday, leaders of Operation Warp Speed said that two coronavirus vaccines could receive emergency use authorization from the FDA in the coming weeks.In addition, Dr. Moncef Slaoui, who is the scientific head of Operation Warp Speed, projected that up to 20 million coronavirus vaccines could be shipped by the end of the year."If approved, they could be used for immunization in the U.S. population in the month of December," Slaoui said. "And we plan to have enough vaccine doses available for use in the U.S. population to immunize about 20 million individuals in the month of December, and another 25 to 30 million per month on an ongoing basis thereon."Given that doses of the two vaccines come in two doses, it could take many months and be well into 2021 before the majority of the American population is vaccinated against the coronavirus.The update came as the virus spreads throughout the country at an alarming and uncontrolled rate. At least 100,000 Americans are confirmed to have contracted the virus every day for the last 10 days, culminating in a record-shattering 153,000 cases on Thursday. Hospitalizations linked to the virus have reached all-time highs since the pandemic began, and deaths linked to the virus are beginning to tick up as well.The update also comes days after Pfizer announced that its vaccine candidate has been 90% effective in Phase 3 trials. The company says it is on track to apply for Emergency Use Status by the end of the month, meaning that some Americans could receive the vaccine before the year's end.New York Gov. Andrew Cuomo, who said his state would independently review vaccine candidates before authorizing distribution to the state, was a frequent target during Friday’s news briefing.“Vaccines will be allocated pro rata by population so we ensure fair and equitable across. We need the states who are part of the planning to accept the vaccine,” saidArmy General Gustave F. Perna, who is overseeing logistics and distribution for Operation Warp Speed. “We are working closely along with the CDC, the jurisdictions and states to ensure vaccine can safely and quickly get to those who need it first.”Trump blasted Cuomo for utilizing an independent review process separate from the FDA. "We won't be delivering it to New York until we have authorization to do so," Trump said. "That pains me to say that. This is a very successful, amazing vaccine that 90% or more. The governor, Gov. Cuomo will have to let us know when he's ready for it. Otherwise, we can't be delivering it to a state that won't be giving it to its people immediately. I know the people of New York very well, I know they want it. The governor will let us know when he's ready."Pfizer said it expects to have 50 million doses of its vaccine ready for global distribution by the end of 2020, and 1 billion doses globally by the end of 2021. That's why other vaccines are also being looked in hopes of getting as many Americans vaccinated as soon as possible. Trump and others on Operation Warp Speed confirmed that health care workers and the elderly would be first to receive doses of the vaccine. Dr. Anthony Fauci, the Trump administration's top infectious disease expert, predicted earlier this week that the vaccine would be widely available in April.Previously, Trump had suggested that a vaccine would have been approved in October and widely available by the start of 2021. Project Warp Speed leaders, however, credited the federal government's response to the virus even if the vaccine has not been distributed as quickly as previously suggested.Friday's remarks were Trump's first on-camera comments since Joe Biden was projected as the winner of the presidential election. Trump had not delivered comments to the press on-camera since Nov. 5, when at a press conference in the White House press room he falsely claimed he would win the presidential election on still-baseless claims of widespread voter fraud.Trump has appeared on camera just once in the last week — a Veteran's Day appearance at Arlington National Cemetery at which he did not speak.Trump's extended media blackout is out of step with the first four years of his administration. Trump has rarely shied away from speaking with reporters, as he often makes himself available for on-camera interviews with the White House press pool on the front lawn and has taken to calling friendly media outlets for phone interviews.However, since last Thursday, Trump has only delivered statements through his Twitter account, where he has continued to spread misinformation about the 2020 election. In the past week, Twitter has taken action on about 50 of Trump's tweets or retweets — be it adding a link to more information, adding a fact check or hiding the tweet from timelines completely. 4827
AstraZeneca is the latest drugmaker to announce promising Phase 3 trial results from its COVID-19 vaccine candidate.On Monday, AstraZeneca said its two-shot vaccine candidate has been 90% effective thus far along with no safety concerns.“These findings show that we have an effective vaccine that will save many lives," said Professor Andrew Pollard, the chief executive of the study. Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply. Today’s announcement is only possible thanks to the many volunteers in our trial, and the hard working and talented team of researchers based around the world.”The company added in its press release that its vaccine candidate offers two distinct advantages over vaccines made by Pfizer and Moderna — it's cheaper to produce, and does not need to be stored in ultra-cold conditions before use.AstraZeneca added that the company would "immediately" prepare regulatory paperwork to seek Emergency Use Listing status from the World Health Organization.AstraZeneca is just the latest drug company to report encouraging results from its COVID-19 vaccine candidate.Last week, Pfizer said it had submitted Emergency Use Authorization paperwork to the Food & Drug Administration (FDA) after a final analysis of its vaccine candidate proved to be 95% effective in preventing COVID-19. The FDA is expected to approve the drug in the coming weeks.Moderna has also said that early results show its vaccine candidate to be 95% effective, and is on track to have the drug approved for Emergency Use Authorization by the end of the year.AstraZeneca, Pfizer and Moderna are all shattering records for vaccine development. The three vaccines are all on track to be approved for widespread use in uder a year. Typically, it takes several years for a vaccine to go from development to approval.The announcement comes as COVID-19 is spreading around the world at a rate not previously seen since the pandemic began. And while all three companies are pre-producing their vaccines in the hope that it will be approved, health experts warn that they won't be widely available until spring 2021. 2247